MedPath

Efficacy and Safety of Bilateral Theta Burst Stimulation for the Treatment of Auditory Hallucinations

Phase 2
Completed
Conditions
Auditory Hallucinations
Interventions
Procedure: continuous theta burst stimulation (cTBS)
Procedure: sham cTBS
Registration Number
NCT01478880
Lead Sponsor
University Hospital Tuebingen
Brief Summary

First clinical studies indicate an effect of repetitive transcranial magnetic stimulation(rTMS) in the treatment of auditory hallucinations (AH). However, effect size, optimal stimulation site and parameters are unclear. With this randomized, placebo-controlled clinical trial we test the efficacy and safety of bilateral continuous theta burst stimulation (cTBS), a patterned form rTMS, against auditory hallucinations. The treatment will be applied add-on to individual antipsychotic and behavioral therapy. Patients will be treated for 6 weeks each weekday (30 sessions) with 40s of cTBS (halfway between T3/P3 and T4/P4). For weeks 1-3, half of the subjects will be randomized to a sham-stimulation (coil tilted 45°). During weeks 4-6, all subjects receive real cTBS.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • auditory hallucinations at least once a week
  • Schizophrenia (DSM-IV)
  • stable treatment setting (in- or out-patient)
  • no change of antipsychotics during and at least 1 week before treatment initiation
Exclusion Criteria
  • epilepsy
  • benzodiazepines > 1,5mg lorazepam / d
  • pregnancy
  • metal parts in the brain
  • cardiac pacemaker
  • deep brain stimulation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
cTBScontinuous theta burst stimulation (cTBS)-
Sham cTBSsham cTBS-
Primary Outcome Measures
NameTimeMethod
Psychotic Symptom Rating Scales (PSYRATS), subscale for auditory hallucinations3 weeks

Change of PSYRATS AH score compared to baseline after 3 weeks of treatment

Secondary Outcome Measures
NameTimeMethod
Hallucination change score (HCS)3 and 6 weeks
Positive and Negative Symptom Scale (PANSS)3 and 6 weeks
PSYRATS subscale for auditory hallucinations6 weeks

Change of PSYRATS AH score compared to baseline after 6 weeks of treatment

Trial Locations

Locations (1)

University of Tübingen, Department of Psychiatry and Psychotherapy

🇩🇪

Tübingen, Germany

© Copyright 2025. All Rights Reserved by MedPath